The role of URO17™ biomarker to enhance diagnosis of urothelial cancer in new hematuria patients—First European Data

INTRODUCTION AND OBJECTIVES: Novel biomarker research is vital for the progression of safe and thorough diagnostic medicine. There is now a need to improve the diagnosis of bladder cancer via a noninvasive urine test while balancing the risks of harm from investigational procedures, such as cystosco...

Descripción completa

Detalles Bibliográficos
Autores principales: Vasdev, Nikhil, Hampson, Alexander, Agarwal, Samita, Swamy, Rajiv, Chilvers, Michael, Hampson, Amy, Jahanfard, Sholeh, Kim, Nam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988772/
https://www.ncbi.nlm.nih.gov/pubmed/35474659
http://dx.doi.org/10.1002/bco2.50

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988772/
https://www.ncbi.nlm.nih.gov/pubmed/35474659
http://dx.doi.org/10.1002/bco2.50

Ejemplares similares